Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors
暂无分享,去创建一个
D. Cines | V. Krymskaya | Y. Parfyonova | K. Dergilev | Z. Tsokolaeva | F. Zabozlaev | E. Atochina-Vasserman | V. Stepanova | S. Zaitsev | K. Obraztsova | M. Teter | S. P. Lewis | Kelci R Holman | A. Volgina | S. Lewis